You are here

Press Releases

Press Release | February 12, 2020

WASHINGTON, D.C. The Advanced Medical Technology Association (AdvaMed) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither practical nor is it based on the latest science, and pursuing it could pose an increased risk to public health through supply chain and distribution threats.

Press Release | February 11, 2020

WASHINGTON, D.C. – This week, AdvaMed President and CEO, Scott Whitaker, and AdvaMed CFO and Executive Director of AdvaMed Advance, Jennifer Brearey, co-authored an editorial outlining steps the medical technology industry is taking to cultivate more diverse, more inclusive workplace cultures.

Press Release | February 10, 2020
Mark Brager
mbrager@advamed.org

WASHINGTON and SAN DIEGO – February 10, 2020 – The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s Digital MedTech Conference, the single event will highlight the evolving digital medtech landscape and explore trends impacting the industry, all while bringing together key leaders from California and beyond. The conference will take place at the Millennium Biltmore Hotel in Los Angeles from May 19-20, 2020.  

Press Release | January 29, 2020

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the signing into law of the United States-Mexico-Canada Agreement (USMCA) by President Trump:

Press Release | January 28, 2020

WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the emergence of the coronavirus:

Press Release | January 8, 2020

WASHINGTON, D.C. - Today, the Advanced Medical Technology Association (AdvaMed) announced that AdvaMed President and CEO Scott Whitaker signed the CEO Action for Diversity and Inclusion pledge, the largest CEO-driven business commitment to advance diversity and inclusion within the workplace: "We believe the medical technology industry should be an industry of choice for people of all backgrounds."

Press Release | December 20, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on President Trump's signing of legislation to repeal the medical device excise tax:  

Press Release | December 19, 2019

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the broader government funding agreement expected to be signed into law this week by President Trump:

Press Release | December 19, 2019
Mark Brager
mbrager@advamed.org

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax:

“On behalf of the entire medtech industry and the patients we serve, we thank the Senate for passing legislation to repeal the medical device excise tax once and for all. Without the leadership of Majority Leader Mitch McConnell and Minority Leader Chuck Schumer, as well as that of Sen. Pat Toomey and all the cosponsors of the device tax repeal legislation, the industry would be facing massive job losses and cuts to the very research and development we need to save and improve patients’ lives. Patients are the real winners here today.

“We look forward to the president signing this legislation into law.”

# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

Press Release | December 17, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device excise tax:

Pages